| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ARALEZ PHARMACEUTICALS INC | 68,143 | 330,000 | 0.00% | ||
| 2 | ALIMERA SCIENCES INC | 250,000 | 373,000 | 0.00% | ||
| 3 | Nivalis Therapeutics Inc | 59,000 | 480,000 | 0.01% | ||
| 4 | XTANT MED HLDGS INC | 475,439 | 537,000 | 0.01% | ||
| 5 | BIOMARIN PHARMACEUTICAL INC 0.75 10/15/2018 | 500,000 | 600,000 | 0.01% | PRN | |
| 6 | BIOMARIN PHARMACEUTICAL INC SR SB CONV NT 20 | 500,000 | 624,000 | 0.01% | PRN | |
| 7 | PERNIX THERAPEUTICS HLDGS IN | 1,073,000 | 668,000 | 0.01% | ||
| 8 | MEDIGUS LTD | 600,000 | 756,000 | 0.01% | ||
| 9 | QLT INC | 500,000 | 1,030,000 | 0.01% | ||
| 10 | Marinus Pharmaceuticals Inc | 567,600 | 1,033,000 | 0.01% | ||
| 11 | AMARIN CORP PLC | 350,000 | 1,117,000 | 0.01% | ||
| 12 | BIOLINERX LTD | 1,038,600 | 1,194,000 | 0.01% | ||
| 13 | INTRA-CELLULAR THERAPIES INC | 90,000 | 1,373,000 | 0.02% | Call | |
| 14 | OREXIGEN THERAPEUTICS INC | 5,210,000 | 1,441,000 | 0.02% | PRN | |
| 15 | COGENTIX MED INC | 878,145 | 1,598,000 | 0.02% | ||
| 16 | ROKA BIOSCIENCE INC | 3,220,429 | 2,238,000 | 0.03% | ||
| 17 | AMEDISYS INC COM | 71,500 | 3,392,000 | 0.04% | ||
| 18 | PERNIX THERAPEUTICS HOLDINGS INC | 12,000,000 | 3,514,000 | 0.04% | PRN | |
| 19 | UNIQURE NV | 489,000 | 3,741,000 | 0.04% | ||
| 20 | SANGAMO THERAPEUTICS INCORPORATED | 831,500 | 3,850,000 | 0.04% | ||
| 21 | INVITAE CORP | 456,666 | 4,000,000 | 0.05% | ||
| 22 | VALEANT PHARMACEUTICALS INTL | 194,900 | 4,785,000 | 0.05% | ||
| 23 | GW PHARMACEUTICALS PLC | 36,200 | 4,805,000 | 0.05% | ||
| 24 | INFINITY PHARMACEUTICALS INC | 3,250,300 | 5,070,000 | 0.06% | ||
| 25 | ADAPTIMMUNE THERAPEUTICS PLC | 724,184 | 5,105,000 | 0.06% | ||
| 26 | BRISTOL MYERS SQUIBB CO | 100,000 | 5,392,000 | 0.06% | Call | |
| 27 | FLUIDIGM CORP DEL | 10,000,000 | 6,213,000 | 0.07% | PRN | |
| 28 | REDHILL BIOPHARMA LTD | 564,900 | 7,846,000 | 0.09% | ||
| 29 | MINERVA NEUROSCIENCES INC COM | 556,200 | 7,851,000 | 0.09% | ||
| 30 | INCYTE CORP SR CV NT0.375 18 | 4,250,000 | 8,090,000 | 0.09% | PRN | |
| 31 | XENON PHARMACEUTICALS INC | 1,000,000 | 8,100,000 | 0.09% | ||
| 32 | NUVASIVE INC | 123,500 | 8,233,000 | 0.09% | ||
| 33 | SIENTRA INC | 917,500 | 8,248,000 | 0.09% | ||
| 34 | INCYTE CORP | 4,250,000 | 8,267,000 | 0.09% | PRN | |
| 35 | PORTOLA PHARMACEUTICALS INC | 370,900 | 8,423,000 | 0.10% | ||
| 36 | CELLECTIS S A | 350,000 | 8,428,000 | 0.10% | ||
| 37 | AEGLEA BIOTHERAPEUTICS INC | 1,360,224 | 8,719,000 | 0.10% | ||
| 38 | ADR - Nabriva Therapeutics AG- Usd | 1,315,000 | 9,271,000 | 0.11% | ||
| 39 | AFFIMED N V COM | 3,375,000 | 9,383,000 | 0.11% | ||
| 40 | INOTEK PHARMACEUTICALS CORP | 7,000,000 | 9,547,000 | 0.11% | PRN | |
| 41 | ASSEMBLY BIOSCIENCES INC | 1,397,100 | 10,073,000 | 0.11% | ||
| 42 | SAGE THERAPEUTICS INC | 235,400 | 10,840,000 | 0.12% | ||
| 43 | STEADYMED LTD | 3,072,196 | 11,029,000 | 0.13% | ||
| 44 | Syndax Pharmaceuticals Inc | 757,365 | 11,482,000 | 0.13% | ||
| 45 | ALLERGAN PLC | 50,000 | 11,516,000 | 0.13% | Call | |
| 46 | ULTRAGENYX PHARMACEUTICAL INC COM | 169,300 | 12,010,000 | 0.14% | ||
| 47 | IMMUNOMEDICS INCORPORATED | 3,802,000 | 12,357,000 | 0.14% | ||
| 48 | VANDA PHARMACEUTICALS INC COM | 750,000 | 12,480,000 | 0.14% | Call | |
| 49 | DBV TECHNOLOGIES S A | 345,700 | 12,559,000 | 0.14% | ||
| 50 | BARD C R INC | 58,000 | 13,008,000 | 0.15% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001172661-16-004318, filed 2016.11.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
